Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism SDCBP inhibitors(syndecan binding protein inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Bone metastases | Preclinical | United States | 01 May 2026 | |
| Metastatic Prostate Carcinoma | Preclinical | United States | 01 May 2026 |





